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Abstract Iron regulatory protein 2 (IRP2) is one of the central
regulators of iron homeostasis. IRP2 regulates expression of
molecules involved in iron metabolism by binding to iron
responsive elements (IREs) in the transcripts of those molecules
in iron depletion. IRP2 is regulated by the accelerated
degradation initiated by the iron-catalyzed oxidation. Here we
report that aluminum antagonizes the iron-induced decrease in
IRE binding activity of IRP2. Aluminum also inhibits iron-
induced oxidation of IRP2 in vitro. These results suggest that
aluminum stabilizes IRP2 by interfering with the iron-catalyzed
oxidation, which results in perturbation of iron metabolism.
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1. Introduction
The expression of proteins involved in mammalian iron
metabolism are regulated post-transcriptionally through inter-
actions between RNA stem-loop structures known as iron
responsive elements (IREs) and iron regulatory proteins 1
and 2 (IRP1 and 2) (reviewed in [1,2]). The binding of IRPs
to IREs in the 5P untranslated region (UTR) prevents initia-
tion of the translation of ferritin mRNA [3,4], and the binding
of IRPs to IREs in the 3P UTR of transferrin receptor (TfR)
mRNA protects the mRNA from degradation in iron-de-
pleted cells [5,6].
Both IRP1 and IRP2 bind IREs with high a⁄nity only in
iron-depleted cells, but the mode of regulation by iron di¡ers
between the two proteins. IRP1 is a stable bifunctional pro-
tein [7,8], whereas IRP2 is rapidly degraded in the presence of
iron in cells [9,10], with the IRP2-speci¢c domain consisting of
73 amino acids functioning as an iron-dependent degradation
domain [11].
The introduction of a constitutive IRE binding IRP1 mu-
tant perturbed the expression of TfR and ferritin and de-
creased cell survival possibly due to the iron toxicity [12].
Although both IRP1 and IRP2 are expressed in almost all
organs and cell lines, a murine pro-B cell line, Ba/F3, has
been shown to lack IRP1 and expresses only IRP2 [13]. TfR
and ferritin are fully regulated by IRP2 in Ba/F3, suggesting
that the presence of IRP2 is su⁄cient for the IRE-mediated
iron regulation. Therefore, it is important to identify the in-
ducer of IRP2. An IRP2-speci¢c inducer, however, has not
been identi¢ed to date. Nitric oxide (NO) has been claimed as
an enhancer of IRP2 [14], but con£icting reports showed that
IRP2 was insensitive to NO [15]. The degradation of IRP2 has
been shown to be initiated by the oxidative modi¢cation of
the protein by iron [16]. It is highly likely that other metals
that a¡ect the redox cellular state will have an e¡ect on IRE
binding, however, such an e¡ect has not been shown. Here,
we demonstrate that aluminum induces the IRE binding ac-
tivity of IRP2 by competitively inhibiting the oxidative mod-
i¢cation of the protein by iron, which results in elevated TfR
biosynthesis and the suppression of ferritin production.
2. Materials and methods
2.1. Cell culture
A murine erythroleukemia cell line, MEL, and a murine neuroblas-
toma cell line, Neuro2A, were maintained in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) with 10% fetal calf serum (FCS; Gibco-
BRL), 100 IU/ml penicillin G and 100 Wg/ml streptomycin. A murine
pro-B cell line, Ba/F3, was cultured in RPMI 1640 medium with 10%
FCS, penicillin G, streptomycin, 50 WM of 2-mercaptoethanol, and
100 U/ml murine interleukin-3. These cells are cultured with AlCl3,
MnCl2, CuSO4, ZnSO4 (Wako, Japan), ferric ammonium citrate
(FAC), hemin, or the iron chelator desferrioxamine (Df; Ciba-Geigy).
2.2.. Preparation of cell extracts
Lysates for RNA gel shift assay and Western blot were prepared by
lysing cells with lysis bu¡er containing 1% Triton X-100, 25 mM Tris-
HCl pH 7.4, 40 mM KCl, protease inhibitors (10 Wg/ml aprotinin,
5 Wg/ml leupeptin, and 1 mM phenylmethylsulfonyl £uoride) on ice.
Nuclei and membrane fractions were removed by centrifugation.
2.3. RNA gel retardation assay
Gel retardation assays were performed as described previously [11].
Brie£y, 15 Wg of cell lysates were incubated with 2 ng of 32P-labelled
IRE probe for 10 min on ice. The mixture was separated in 10% non-
denaturing polyacrylamide gel.
2.4. Western blots
Lysates (50 Wg) were separated in 6% SDS-PAGE and transferred
to nitrocellulose membranes (Schleicher and Schuell), then incubated
with rabbit a⁄nity-puri¢ed anti-IRP2 antibody [9], followed by incu-
bation with horseradish peroxidase-conjugated anti-rabbit IgG
(Amersham-Pharmacia Biotech), and visualized with the SuperSignal
Western blotting detection system (Pierce).
2.5. Northern blots
RNA was extracted from cells by the acid guanidinium thiocyanate-
phenol-chloroform extraction method [17]. 20 Wg of total RNAs were
electrophoresed, then transferred onto nylon membrane (Hybond N,
Amersham-Pharmacia Biotech). The membrane was hybridized with
radiolabelled murine TfR, ferritin H chain, and GAPDH cDNA
probes. Quantitation was performed using the BAS 2000 image ana-
lyzer (Fuji Film).
2.6. Biosynthetic labelling
Cells were metabolically radiolabelled with 3.7 MBq/ml of Pro-mix
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(Amersham-Pharmacia Biotech) in methionine- and cystine-de¢cient
DMEM containing 10% dialyzed FCS for 3.5 h in the continuous
presence of the metals. Aliquots of lysates containing 4U107 cpm,
determined by trichloroacetic acid precipitation, were immunoprecipi-
tated with polyclonal anti-ferritin IgG (Boehringer Mannheim) or rat
anti-mouse TfR antibody (R17 217) followed by rabbit anti-rat IgG
(Zymed, South San Francisco, CA, USA) and separated in 7% or 13%
SDS-PAGE for TfR or ferritin, respectively.
2.7. Carbonyl detection assay
Puri¢cation of baculovirus-expressed IRP2 was performed as de-
scribed previously [9]. 4 Wg of the recombinant IRP2 were incubated
with FeCl3 (Sigma), dithiothreitol (DTT) (Wako, Japan), AlCl3,
CuSO4, or ZnSO4 in 25 mM HEPES pH 7.2, 40 mM KCl at 37‡C.
Reactions were stopped by the addition of Df to 1 mM. The detection
of carbonyl residues of the proteins was performed as described [16].
3. Results
3.1. Aluminum induces the IRE binding activity of IRP2 by
antagonizing the e¡ect of iron in MEL cells
To examine the in£uence of metals on the IRE binding
activity of IRPs, 100 WM of aluminum, manganese, copper,
and zinc were added to cultures of an erythroleukemic cell
line, MEL, and an RNA gel mobility shift assay was per-
formed. The IRE binding activities of both IRP1 and IRP2
were strongly induced by the administration of the iron-spe-
ci¢c chelator, Df, and were strongly suppressed in the pres-
ence of FAC as reported [9,19]. The IRE binding activity of
IRP2 was speci¢cally induced in the presence of aluminum,
but not in the presence of other metals (Fig. 1A). We also
examined the amount of IRP2 protein by Western blot. The
increase in the IRE binding activity of IRP2 coincided with
the increase in the amount of IRP2 induced by aluminum
(Fig. 1B), suggesting that induction of the IRE binding activ-
ity by aluminum is due to the accumulation of IRP2 protein.
To analyze the mechanism of the aluminum-induced IRE
binding activity of IRP2, we treated MEL cells with alumi-
num chloride together with indicated concentrations of FAC
(Fig. 1C,D) or hemin (Fig. 1E,F) as an iron source. The
aluminum-induced IRE binding activity and amount of
IRP2 decreased in a FAC or hemin dose-dependent fashion.
To titrate the concentration of aluminum on IRP2, we treated
MEL cells with di¡erent concentrations of aluminum in the
presence of FAC. IRE binding activity of IRP2 increased in a
dose-dependent fashion (Fig. 1G). Taken together, these re-
sults indicate that aluminum induces the IRE binding of IRP2
by antagonizing the e¡ect of iron.
3.2. Enhanced IRE binding activity of IRP2 by aluminum
increases the production of TfR and suppresses ferritin
synthesis in MEL cells
We next analyzed the physiological signi¢cance of the alu-
minum-induced IRE binding activity of IRP2 in MEL cells.
To examine the e¡ect of induced IRE binding activity of IRP2
by aluminum on the amount of TfR mRNA, Northern blot
analyses were performed. The induction of the IRE binding
activity of IRP2 by the aluminum was con¢rmed by gel mo-
bility shift analysis (data not shown). TfR mRNA was abun-
dant in cells treated with Df, and was minimal in cells treated
with FAC (Fig. 2A). The amount of TfR mRNA was in-
creased 2.7-fold in cells treated with FAC in the presence of
aluminum compared to cells treated with FAC alone. Ferritin
and GAPDH mRNAs were not signi¢cantly a¡ected by the
presence of aluminum (Fig. 2A). We also followed the e¡ect
of aluminum on the biosynthesis of TfR in MEL cells (Fig.
2B). TfR synthesis was strongly induced by Df and was sup-
pressed by FAC. However, the suppression of TfR synthesis
by iron was signi¢cantly reversed by the addition of aluminum
(1.6-fold). Biosynthesis of ferritin was monitored after the
treatment of MEL cells with FAC in the presence or absence
of aluminum (Fig. 2C). Ferritin production was induced in the
presence of FAC. This induction by FAC was signi¢cantly
suppressed by the presence of aluminum (0.6-fold). These re-
sults show that aluminum suppresses the production of ferri-
tin, and stimulates TfR biosynthesis by stabilizing its mRNA
through the induction of the IRE binding activity of IRP2.
Fig. 1. Aluminum induces the IRE binding activity of IRP2 by
competing with iron in MEL cells. MEL cells were treated with
300 WM FAC (F), 100 WM AlCl3 (Al), 100 WM MnCl2 (Mn),
100 WM CuSO4 (Cu), or 100 WM ZnSO4 (Zn) for 48 h, together
with non-treated control (3) and cells treated with 100 WM Df for
16 h (D). A: Gel retardation assay. Lysates (15 Wg) were incubated
with radiolabelled IRE and electrophoresed in 10% native polyacryl-
amide gel. B: Western blot analysis of IRP2 using rabbit a⁄nity-pu-
ri¢ed anti-IRP2 antibody. MEL cells were treated with the indicated
concentrations of FAC (C, D) or hemin (E, F) in the presence (+)
or absence (3) of 100 WM of AlCl3 for 48 h. The same samples
were assessed by gel retardation assays (C, E) and Western blots for
IRP2 (D, F). MEL cells were treated with the indicated concentra-
tions of AlCl3 in the presence of 6 WM FAC for 48 h, and lysates
were assessed by gel retardation assays (G).
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3.3. Induction of the IRE binding activity of IRP2 by aluminum
in neuronal cells and pro-B lymphoid cells
To exclude the possibility that the e¡ect of aluminum is a
unique feature of iron metabolism in an erythroid cell line,
MEL, we analyzed the e¡ect of aluminum on IRP2 in a mur-
ine neuroblastoma cell line, Neuro 2A, or an IRP1-defective
murine pro-B cell line, Ba/F3. Increasing concentrations of
FAC were added to the cultures of Neuro 2A or Ba/F3 cells
along with 500 WM aluminum (Fig. 3A,B). Gel mobility shift
assays showed that the IRE binding activity of IRP2 was
speci¢cally increased by the aluminum in the presence of
FAC. Due to the competition between the two metals, the
e¡ect of aluminum on IRP2 could not be observed any
more in the presence of 300 WM FAC. We then examined
the e¡ect of aluminum on TfR or ferritin production in Neuro
2A or Ba/F3 cells. The e¡ects of aluminum in these cell lines
are similar to those observed in MEL cells (Fig. 3C^F), sug-
gesting that aluminum suppresses the production of ferritin,
and stimulates TfR biosynthesis through the induction of the
IRE binding activity of IRP2, and these observations are
common to many cell lines.
3.4. Iron-induced oxidative modi¢cation of IRP2 is inhibited by
the presence of aluminum in vitro
Since the oxidative modi¢cation of IRP2 by iron has been
shown to signal the protein for degradation via the ubiquitin-
proteasome pathway [16], it was important to monitor the
e¡ect of aluminum on iron-induced oxidative modi¢cation
of IRP2 in vitro. IRP2 was incubated with FeCl3 and DTT
in the presence or absence of AlCl3, CuSO4, or ZnSO4, then
oxidative modi¢cation of IRP2 was monitored as described
before [16,18]. As shown in Fig. 4A, IRP2 was oxidized in a
time-dependent fashion in the presence of FeCl3 (lanes 2, 3).
Aluminum could inhibit the oxidative modi¢cation over the
same incubation periods, however copper and zinc could not
(lanes 4^9). Neither aluminum, copper, nor zinc alone could
induce oxidation of IRP2 (lanes 10^12). Coomassie staining of
the membrane showed equal amounts of IRP2 were loaded
(Fig. 4B). These results suggested that the inhibition of the
iron-induced oxidative modi¢cation of IRP2 was speci¢c to
aluminum. To titrate the e¡ect of aluminum on the IRP2
protein, we next incubated IRP2 with increasing concentra-
tions of AlCl3 in the presence of FeCl3 (Fig. 4C), and the
oxidative changes were monitored. IRP2 was oxidized in the
presence of either 10 WM (lane 14) or 20 WM (lane 18) FeCl3,
however, these modi¢cations were suppressed by aluminum in
a dose-dependent fashion in the presence of both 10 WM
(lanes 15^17) and 20 WM (lanes 19^21) of FeCl3. Coomassie
Fig. 2. Aluminum stimulates TfR production by stabilizing its
mRNA and suppresses ferritin biosynthesis in MEL cells. A: MEL
cells were treated with 6 WM FAC (F) in the presence (Al) or ab-
sence (3) of 100 WM AlCl3 for 48 h. Control cells were treated with
100 WM Df for 16 h (D). Northern blot for TfR, ferritin H chain,
and GAPDH RNA levels in MEL cells were performed. B, C:
MEL cells were treated under the same condition as in A. Cells
were labelled metabolically, and biosynthesis of TfR or ferritin was
assessed as described in Section 2. Arrows indicate TfR (B) or ferri-
tin H and L chains (C).
Fig. 3. Aluminum suppresses ferritin biosynthesis and increases TfR
production via increased IRE binding activity of IRP2 in Neuro 2A
cells and Ba/F3 cells. Neuro 2A cells (A) or Ba/F3 cells (B) were in-
cubated with the indicated concentration of FAC in the presence
(+) or absence (3) of 500 WM of AlCl3 for 48 h. Lysates were as-
sessed by gel retardation assays (A, B). Neuro 2A cells (C, D) or
Ba/F3 cells (E, F) were incubated with (Al) or without (3) 500 WM
AlCl3 in the presence of 150 WM or 75 WM FAC (F) for 48 h, re-
spectively. Cells that were incubated with 100 WM Df for 16 h were
used as controls (D). Cells were labelled metabolically, and biosyn-
thesis of TfR or ferritin was monitored as described in Section 2.
Arrows indicate TfR (C, E) or ferritin H and L chains (D, F).
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staining of the membrane revealed that equal amounts of
IRP2 protein were loaded (Fig. 4D). Collectively, these results
indicate that aluminum competitively inhibits the iron-cata-
lyzed oxidative modi¢cation of IRP2.
4. Discussion
IRPs are the central regulators of iron metabolism in mam-
malian cells. They act by modulating the expression of the
molecules involved in iron metabolism through the speci¢c
binding to IREs on the transcripts of the respective genes
under conditions of iron depletion. Administration of iron
to Neuro 2A cells leads to the induction of hsp70 [20], as
the metal is an inducer of oxidative stress. Thus, identi¢cation
of iron-independent inducers of IRPs has broad biological
implications. In this report, we identi¢ed aluminum as an
IRP2-speci¢c enhancing agent.
Aluminum is known to be taken up by cells via the Tf/TfR
pathway [21]. Therefore, the e¡ect of aluminum on the accu-
mulation of IRP2 may be due to its inhibition of transferrin
receptor-mediated iron uptake, which leads to a decrease in
the cellular iron concentration. However, this is not the only
explanation as aluminum also induces the IRE binding activ-
ity of IRP2 in the presence of hemin, which is known to be
taken up via a transferrin-independent pathway (Fig. 1E,F).
The IRE binding activity of IRP2 has been shown to be
regulated by rapid degradation of the protein in the presence
of iron [9]. In addition, the oxidative modi¢cation of IRP2 by
iron has been shown to be the ¢rst event in the iron-depend-
ent degradation of the protein via the ubiquitin-proteasome
pathway [16]. It has been shown that the direct binding of
iron to proteins leads to metal-catalyzed oxidation of amino
acid residues in the vicinity of the metal binding sites in the
presence of reducing agents and molecular oxygen [22]. How-
ever, the iron binding site(s) of IRP2, which appears to be
critical for the oxidative modi¢cation of the protein, has not
been identi¢ed. When added to cultured cells, manganese,
copper, and zinc could not induce the IRE binding activity
of IRP2 in cells (Fig. 1A). Neither copper nor zinc could
inhibit the iron-catalyzed oxidation of IRP2 in vitro even
when excess amounts of the metals are used (Fig. 4A). We
showed aluminum induced IRE binding activity of IRP2 in
cells (Fig. 1C^G) and inhibited oxidation of IRP2 in vitro
(Fig. 4C,D). These e¡ects of aluminum were competitive to
that of iron. Taken together, these observations strongly in-
dicate that iron binding site(s) are present in IRP2 and that
the a⁄nity of aluminum to the iron binding site of IRP2
seems to be much higher than other metals. Hanson et al.
have reported that cobalt increased the amount of IRP2 pro-
tein, suggesting that cobalt also has substantial a⁄nity for the
iron binding site of IRP2 [23]. However, cobalt cannot per-
turb iron metabolism through IRP2 since they also showed
that cobalt-induced IRP2 lacked IRE binding activity [23].
The iron-independent induction of the IRE binding activity
leads to enlargement of the cytoplasmically available iron
pool, which results in an increase in reactive oxygen species
in cells [12]. IRP2 is preferentially expressed in the intestine
and brain [9]. In the neuronal cell line, Neuro 2A, IRP2 was
stabilized by aluminum. Aluminum has been shown to be the
critical agent for dialysis dementia [24]. Our results suggest the
possibility that the neurotoxicity induced by aluminum may
be provoked by the perturbation of cellular iron regulation
through stabilization of IRP2. Accumulation of reactive iron,
aluminum, IRP2 has been noted in the tangles of Alzheimer
lesions [25^27], but the involvement of aluminum in the
pathogenesis of the disease is still controversial. Therefore,
the identi¢cation of other inducing agents of the IRE binding
of IRP2, and further analyses of the relationship between
neurotoxicity and the accumulation of IRP2 will elucidate
the roles of IRP2 in those disorders.
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